v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
2022 Sales Agreement [Member]
Follow On Public Offering
At The Market Offerings
At The Market Offerings
2019 Sales Agreement [Member]
At The Market Offerings
2022 Sales Agreement [Member]
Common Stock
Common Stock
Follow On Public Offering
Common Stock
At The Market Offerings
Common Stock
At The Market Offerings
2019 Sales Agreement [Member]
Common Stock
At The Market Offerings
2022 Sales Agreement [Member]
Additional Paid-In Capital
Additional Paid-In Capital
Follow On Public Offering
Additional Paid-In Capital
At The Market Offerings
Additional Paid-In Capital
At The Market Offerings
2019 Sales Agreement [Member]
Additional Paid-In Capital
At The Market Offerings
2022 Sales Agreement [Member]
Accumulated Other Comprehensive Income
Retained Earnings
Beginning balance at Dec. 31, 2020 $ 527,072           $ 7         $ 962,173         $ 1 $ (435,109)
Beginning balance, shares at Dec. 31, 2020             66,234,056                      
Issuance of common stock     $ 648,315 $ 45,255                 $ 648,315 $ 45,255        
Issuance of common stock, shares               4,758,620 641,709                  
Exercise of stock options 41,094                     41,094            
Exercise of stock options, shares             2,700,886                      
Vesting of restricted stock units, shares             119,715                      
Issuance of shares under employee stock purchase plan 2,024                     2,024            
Issuance of shares under employee stock purchase plan, shares             30,897                      
Stock-based compensation 47,009                     47,009            
Other comprehensive loss - unrealized gain (loss) on marketable securities (2,126)                               (2,126)  
Other comprehensive loss - equity method investment (507)                               (507)  
Net Income (Loss) (267,892)                                 (267,892)
Ending balance at Dec. 31, 2021 1,040,244           $ 7         1,745,870         (2,632) (703,001)
Ending balance, shares at Dec. 31, 2021             74,485,883                      
Issuance of common stock     $ 337,892   $ 38,886 $ 189,011   $ 1   $ 1     $ 337,891   $ 38,885 $ 189,011    
Issuance of common stock, shares   3,395,339           7,532,751   579,788 3,395,339              
Exercise of stock options 14,517                     14,517            
Exercise of stock options, shares             883,954                      
Vesting of restricted stock units, shares             147,674                      
Issuance of shares under employee stock purchase plan 2,649                     2,649            
Issuance of shares under employee stock purchase plan, shares             77,618                      
Stock-based compensation 91,400                     91,400            
Other comprehensive loss - unrealized gain (loss) on marketable securities (1,637)                               (1,637)  
Other comprehensive loss - equity method investment (3,192)                               (3,192)  
Net Income (Loss) (474,186)                                 (474,186)
Ending balance at Dec. 31, 2022 $ 1,235,584           $ 9         2,420,223         (7,461) (1,177,187)
Ending balance, shares at Dec. 31, 2022 87,103,007           87,103,007                      
Issuance of common stock           $ 121,870                   $ 121,870    
Issuance of common stock, shares   4,122,824                 4,122,824              
Contingent consideration paid, shares             567,045                      
Contingent consideration paid $ 24,126                     24,126            
Exercise of stock options $ 6,599                     6,599            
Exercise of stock options, shares 385,130           385,130                      
Vesting of restricted stock units, shares             677,055                      
Issuance of shares under employee stock purchase plan $ 3,929                     3,929            
Issuance of shares under employee stock purchase plan, shares             142,097                      
Stock-based compensation 134,050                     134,050            
Other comprehensive loss - unrealized gain (loss) on marketable securities 3,635                               3,635  
Other comprehensive loss - equity method investment 1,568                               1,568  
Net Income (Loss) (481,192)                                 (481,192)
Ending balance at Dec. 31, 2023 $ 1,050,169           $ 9         $ 2,710,797         $ (2,258) $ (1,658,379)
Ending balance, shares at Dec. 31, 2023 92,997,158           92,997,158